LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 76.75 | 770.25 | 9100 | 11262 | 0.8080 | 0.8928 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 78.98 | 770.25 | 11358 | 11518 | 0.9861 | 0.9928 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 78.98 | 770.25 | 9199 | 11518 | 0.7987 | 0.8880 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 81.20 | 770.25 | 11736 | 11766 | 0.9974 | 0.9987 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 81.20 | 770.25 | 9403 | 11766 | 0.7991 | 0.8892 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 83.42 | 770.25 | 12119 | 12031 | 1.0072 | 1.0036 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 83.42 | 770.25 | 9491 | 12031 | 0.7888 | 0.8839 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 85.64 | 770.25 | 12493 | 12287 | 1.0167 | 1.0083 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 85.64 | 770.25 | 9708 | 12287 | 0.7901 | 0.8855 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 87.86 | 770.25 | 12915 | 12543 | 1.0296 | 1.0146 | MN20160304_L02 | F19 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 87.86 | 770.25 | 9884 | 12543 | 0.7880 | 0.8851 | MN20160304_L02 | G06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 3.21 | 770.25 | 805 | 904 | 0.8899 | 0.2095 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 3.21 | 770.25 | 1042 | 904 | 1.1519 | 2.6786 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 5.44 | 770.25 | 882 | 1012 | 0.8709 | 0.4093 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 5.44 | 770.25 | 1114 | 1012 | 1.1000 | 1.5458 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 7.66 | 770.25 | 911 | 1090 | 0.8358 | 0.3980 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 7.66 | 770.25 | 1190 | 1090 | 1.0917 | 1.3830 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 10.06 | 770.25 | 1053 | 1218 | 0.8642 | 0.6041 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 10.06 | 770.25 | 1345 | 1218 | 1.1038 | 1.3220 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 12.28 | 770.25 | 1164 | 1358 | 0.8571 | 0.6564 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 12.28 | 770.25 | 1487 | 1358 | 1.0949 | 1.2343 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 14.50 | 770.25 | 1292 | 1497 | 0.8629 | 0.7150 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 14.50 | 770.25 | 1644 | 1497 | 1.0980 | 1.2048 | MN20160304_L02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 16.73 | 770.25 | 1314 | 1664 | 0.7894 | 0.6168 | MN20160304_L02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 16.73 | 770.25 | 1731 | 1664 | 1.0400 | 1.0717 | MN20160304_L02 | I20 |